View Item 

Show simple item record

Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

dc.contributor.authorMiller, Richard A.en_US
dc.contributor.authorHarrison, David E.en_US
dc.contributor.authorAstle, Clinton M.en_US
dc.contributor.authorFernandez, Elizabethen_US
dc.contributor.authorFlurkey, Kevinen_US
dc.contributor.authorHan, Melissaen_US
dc.contributor.authorJavors, Martin A.en_US
dc.contributor.authorLi, Xinnaen_US
dc.contributor.authorNadon, Nancy L.en_US
dc.contributor.authorNelson, James F.en_US
dc.contributor.authorPletcher, Scotten_US
dc.contributor.authorSalmon, Adam B.en_US
dc.contributor.authorSharp, Zelton Daveen_US
dc.contributor.authorVan Roekel, Sabrinaen_US
dc.contributor.authorWinkleman, Lynnen_US
dc.contributor.authorStrong, Randyen_US
dc.date.accessioned2014-06-04T14:57:04Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-06-04T14:57:04Z
dc.date.issued2014-06en_US
dc.identifier.citationMiller, Richard A.; Harrison, David E.; Astle, Clinton M.; Fernandez, Elizabeth; Flurkey, Kevin; Han, Melissa; Javors, Martin A.; Li, Xinna; Nadon, Nancy L.; Nelson, James F.; Pletcher, Scott; Salmon, Adam B.; Sharp, Zelton Dave; Van Roekel, Sabrina; Winkleman, Lynn; Strong, Randy (2014). "Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction." Aging Cell 13(3): 468-477.en_US
dc.identifier.issn1474-9718en_US
dc.identifier.issn1474-9726en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/107367
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherLongevityen_US
dc.subject.otherMouseen_US
dc.subject.otherM TORen_US
dc.subject.otherRapamycinen_US
dc.subject.otherXenobiotic Metabolismen_US
dc.subject.otherAgingen_US
dc.subject.otherCaloric Restrictionen_US
dc.subject.otherGlucoseen_US
dc.subject.otherIGF ‐1en_US
dc.subject.otherInsulinen_US
dc.titleRapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restrictionen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/107367/1/acel12194.pdf
dc.identifier.doi10.1111/acel.12194en_US
dc.identifier.sourceAging Cellen_US
dc.identifier.citedreferenceMueller MA, Beutner F, Teupser D, Ceglarek U, Thiery J ( 2008 ) Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR‐/‐ mice despite severe hypercholesterolemia. Atherosclerosis 198, 39 – 48.en_US
dc.identifier.citedreferenceDominici FP, Hauck S, Argentino DP, Bartke A, Turyn D ( 2002 ) Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)‐1 and IRS‐2 in liver of Ames dwarf mice. J. Endocrinol. 173, 81 – 94.en_US
dc.identifier.citedreferenceFlurkey K, Astle CM, Harrison DE ( 2010 ) Life extension by diet restriction and N‐acetyl‐L‐cysteine in genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 65, 1275 – 1284.en_US
dc.identifier.citedreferenceFlynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, Zykovich A, Mooney SD, Strong R, Rosen CJ, Kapahi P, Nelson MD, Kennedy BK, Melov S ( 2013 ) Late‐life rapamycin treatment reverses age‐related heart dysfunction. Aging Cell 15, 851 – 862.en_US
dc.identifier.citedreferenceFok WC, Zhang Y, Salmon AB, Bhattacharya A, Gunda R, Jones D, Ward W, Fisher K, Richardson A, Perez VI ( 2013 ) Short‐term treatment with rapamycin and dietary restriction have overlapping and distinctive effects in young mice. J. Gerontol. A Biol. Sci. Med. Sci. 68, 108 – 116.en_US
dc.identifier.citedreferenceGems D ( 2007 ) Long‐lived dwarf mice: are bile acids a longevity signal? Aging Cell 6, 421 – 423.en_US
dc.identifier.citedreferenceHarrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA ( 2009 ) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392 – 395.en_US
dc.identifier.citedreferenceHarrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, Fernandez E, Flurkey K, Javors MA, Nadon NL, Nelson JF, Simpkins JW, Smith D, Wilkinson JE, Miller RA ( 2013 ) Acarbose, 17‐a‐estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell doi: 10.1111/acel.12170 (in press).en_US
dc.identifier.citedreferenceHidalgo M, Rowinsky EK ( 2000 ) The rapamycin‐sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19, 6680 – 6686.en_US
dc.identifier.citedreferenceHoude VP, Brule S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A ( 2010 ) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59, 1338 – 1348.en_US
dc.identifier.citedreferenceKaeberlein M, Kennedy BK ( 2009 ) Ageing: a midlife longevity drug? Nature 460, 331 – 332.en_US
dc.identifier.citedreferenceKaeberlein M, Powers RW III, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, Kennedy BK ( 2005 ) Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310, 1193 – 1196.en_US
dc.identifier.citedreferenceKapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S ( 2004 ) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14, 885 – 890.en_US
dc.identifier.citedreferenceLadiges W, Van RH, Strong R, Ikeno Y, Treuting P, Rabinovitch P, Richardson A ( 2009 ) Lifespan extension in genetically modified mice. Aging Cell 8, 346 – 352.en_US
dc.identifier.citedreferenceLamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, Davis JG, Salmon AB, Richardson A, Ahima RS, Guertin DA, Sabatini DM, Baur JA ( 2012 ) Rapamycin‐induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638 – 1643.en_US
dc.identifier.citedreferenceLamming DW, Ye L, Astle CM, Baur JA, Sabatini DM, Harrison DE ( 2013 ) Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive. Aging Cell 12, 712 – 718.en_US
dc.identifier.citedreferenceLipman R, Galecki A, Burke DT, Miller RA ( 2004 ) Genetic loci that influence cause of death in a heterogeneous mouse stock. J. Gerontol. Biol. Sci. 59A, 977 – 983.en_US
dc.identifier.citedreferenceLivi CB, Hardman RL, Christy BA, Dodds SG, Jones D, Williams C, Strong R, Bokov A, Javors MA, Ikeno Y, Hubbard G, Hasty P, Sharp ZD ( 2013 ) Rapamycin extends life span of Rb1 + /‐ mice by inhibiting neuroendocrine tumors. Aging (Albany NY) 5, 100 – 110.en_US
dc.identifier.citedreferenceMelo JA, Ruvkun G ( 2012 ) Inactivation of conserved C. elegans genes engages pathogen‐ and xenobiotic‐associated defenses. Cell 149, 452 – 466.en_US
dc.identifier.citedreferenceMiller RA, Chrisp C ( 2002 ) T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice. J. Immunol. 169, 1619 – 1625.en_US
dc.identifier.citedreferenceMiller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Strong R ( 2007 ) An aging interventions testing program: Study design and interim report. Aging Cell 6, 565 – 575.en_US
dc.identifier.citedreferenceMiller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R ( 2011 ) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191 – 201.en_US
dc.identifier.citedreferenceNadon N, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, Peralba JM, Harrison D ( 2008 ). Design of aging intervention studies: the NIA interventions testing program. Age (Dordr) 30, 187 – 199.en_US
dc.identifier.citedreferenceNeff F, Flores‐Dominguez D, Ryan DP, Horsch M, Schroder S, Adler T, Afonso LC, Aguilar‐Pimentel JA, Becker L, Garrett L, Hans W, Hettich MM, Holtmeier R, Holter SM, Moreth K, Prehn C, Puk O, Racz I, Rathkolb B, Rozman J, Naton B, Ordemann R, Adamski J, Beckers J, Bekeredjian R, Busch DH, Ehninger G, Graw J, Hofler H, Klingenspor M, Klopstock T, Ollert M, Stypmann J, Wolf E, Wurst W, Zimmer A, Fuchs H, Gailus‐Durner V, Hrabe de Angelis M, Ehninger D ( 2013 ) Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Invest. 123, 3272 – 3291.en_US
dc.identifier.citedreferenceNelson JF, Strong R, Bokov A, Diaz V, Ward W ( 2012 ) Probing the relationship between insulin sensitivity and longevity using genetically modified mice. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1332 – 1338.en_US
dc.identifier.citedreferenceOrentreich N, Matias JR, DeFelice A, Zimmerman JA ( 1993 ) Low methionine ingestion by rats extends life span. J. Nutr. 123, 269 – 274.en_US
dc.identifier.citedreferencePletcher SD ( 1999 ) Model fitting and hypothesis testing for age‐specific mortality data. J. Evol. Biol. 12, 430 – 440.en_US
dc.identifier.citedreferencePowers RW III, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S ( 2006 ) Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20, 174 – 184.en_US
dc.identifier.citedreferenceSelman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, Claret M, Al‐Qassab H, Carmignac D, Ramadani F, Woods A, Robinson IC, Schuster E, Batterham RL, Kozma SC, Thomas G, Carling D, Okkenhaug K, Thornton JM, Partridge L, Gems D, Withers DJ ( 2009 ) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140 – 144.en_US
dc.identifier.citedreferenceSteinbaugh MJ, Sun LY, Bartke A, Miller RA ( 2012 ) Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan. Am. J. Physiol. Endocrinol. Metab. 303, E488 – E495.en_US
dc.identifier.citedreferenceStrong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Harrison DE ( 2008 ) Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7, 641 – 650.en_US
dc.identifier.citedreferenceStrong R, Miller RA, Astle CM, Baur JA, de Cabo R, Fernandez E, Guo W, Javors M, Kirkland JL, Nelson JF, Sinclair DA, Teter B, Williams D, Zaveri N, Nadon NL, Harrison DE ( 2013 ) Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium‐chain triglyceride oil on life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 68, 6 – 16.en_US
dc.identifier.citedreferenceSun L, Sadighi Akha AA, Miller RA, Harper JM ( 2009 ) Life‐span extension in mice by preweaning food restriction and by methionine restriction in middle age. J. Gerontol. A Biol. Sci. Med. Sci. 64, 711 – 722.en_US
dc.identifier.citedreferenceTinsley FC, Taicher GZ, Heiman ML ( 2004 ) Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes. Res. 12, 150 – 160.en_US
dc.identifier.citedreferenceVellai T, Takacs‐Vellai K, Zhang Y, Kovacs AL, Orosz L, Muller F ( 2003 ) Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426, 620.en_US
dc.identifier.citedreferenceWang C, Li Q, Redden DT, Weindruch R, Allison DB ( 2004 ) Statistical methods for testing effects on “maximum lifespan”. Mech. Ageing Dev. 125, 629 – 632.en_US
dc.identifier.citedreferenceWaxman DJ, Holloway MG ( 2009 ) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 76, 215 – 228.en_US
dc.identifier.citedreferenceWilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA, Miller RA ( 2012 ) Rapamycin slows aging in mice. Aging Cell 11, 675 – 682.en_US
dc.identifier.citedreferenceAmador‐Noguez D, Zimmerman J, Venable S, Darlington G ( 2005 ) Gender‐specific alterations in gene expression and loss of liver sexual dimorphism in the long‐lived Ames dwarf mice. Biochem. Biophys. Res. Commun. 332, 1086 – 1100.en_US
dc.identifier.citedreferenceAnisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Antoch MP, Blagosklonny MV ( 2010 ) Rapamycin extends maximal lifespan in cancer‐prone mice. Am. J. Pathol. 176, 2092 – 2097.en_US
dc.identifier.citedreferenceAnisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Rosenfeld SV, Blagosklonny MV ( 2011 ) Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 10, 4230 – 4236.en_US
dc.identifier.citedreferenceBarlow AD, Nicholson ML, Herbert TP ( 2013 ) Evidence for rapamycin toxicity in pancreatic beta‐cells and a review of the underlying molecular mechanisms. Diabetes 62, 2674 – 2682.en_US
dc.identifier.citedreferenceBarzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L ( 1998 ) Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101, 1353 – 1361.en_US
dc.identifier.citedreferenceBrown‐Borg HM, Borg KE, Meliska CJ, Bartke A ( 1996 ) Dwarf mice and the ageing process. Nature 384, 33.en_US
dc.identifier.citedreferenceCaccamo A, Majumder S, Richardson A, Strong R, Oddo S ( 2010 ) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid‐beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107 – 13120.en_US
dc.identifier.citedreferenceChen C, Liu Y, Liu Y, Zheng P ( 2009 ) mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2, ra75.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acel12194.pdf
Size:
507.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.